Quenching of tryptophan fluorescence in a highly scattering solution: Insights on protein localization in a lung surfactant formulation

CHF5633 (Chiesi Farmaceutici, Italy) is a synthetic surfactant developed for respiratory distress syndrome replacement therapy in pre-term newborn infants. CHF5633 contains two phospholipids (dipalmitoylphosphatidylcholine and 1-palmitoyl-2oleoyl-sn-glycero-3-phosphoglycerol sodium salt), and peptid...

Descripción completa

Detalles Bibliográficos
Autores principales: Ronda, Luca, Pioselli, Barbara, Catinella, Silvia, Salomone, Fabrizio, Marchetti, Marialaura, Bettati, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075776/
https://www.ncbi.nlm.nih.gov/pubmed/30075031
http://dx.doi.org/10.1371/journal.pone.0201926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075776/
https://www.ncbi.nlm.nih.gov/pubmed/30075031
http://dx.doi.org/10.1371/journal.pone.0201926

Ejemplares similares